scholarly journals Ischemic Etiology and Prognosis in Men and Women with Acute Heart Failure

2021 ◽  
Vol 10 (8) ◽  
pp. 1713
Author(s):  
Lourdes Vicent ◽  
Jose Guerra ◽  
Rafael Vazquez-García ◽  
José R. Gonzalez-Juanatey ◽  
Luis Martínez Dolz ◽  
...  

Coronary heart disease is common in heart failure (HF). Our aim was to determine the impact of ischemic etiology on prognosis among men and women with HF. This study is a prospective national multicenter registry. The primary endpoint was 12-month mortality. Patients with HF and ischemic heart disease were stratified according to sex. A total of 1830 patients were enrolled of which 756 (41.3%) were women. Ischemic etiology was more common in men (446 (41.6%)) than in women (167 (22.2%)). Among patients with ischemic HF, diabetes was more frequent in women than in men. Ischemic etiology was not associated with higher mortality risk, and this was true for women (Hazard Ratio [HR] 1.51, 95% Confidence Interval [CI] 0.98–2.32; p = 0.61) and men (HR 1.14, 95% CI 0.81–1.61; p = 0.46), p-value for interaction: 0.067. Mortality/readmission risk in ischemic HF increased in men with previous readmissions (HR 1.15, 95% CI 1.02–1.29; p = 0.022), chronic obstructive pulmonary disease (HR1.20, 95% CI 1.02–1.41; p = 0.026) and in women with diabetes (HR 2.23, 95% CI 1.05–4.47; p = 0.035). Ischemic etiology was not associated with mortality in HF patients. In ischemic HF, the variables associated with a poor prognosis were diabetes in women and previous readmissions and chronic obstructive pulmonary disease in men.

2021 ◽  
Vol 193 ◽  
pp. 111392
Author(s):  
Jonás Carmona-Pírez ◽  
Beatriz Poblador-Plou ◽  
Jesús Díez-Manglano ◽  
Manuel Jesús Morillo-Jiménez ◽  
José María Marín Trigo ◽  
...  

2018 ◽  
Vol 108 (2) ◽  
pp. 185-193 ◽  
Author(s):  
Joseph J. Cuthbert ◽  
Joshua W. Kearsley ◽  
Syed Kazmi ◽  
Anna Kallvikbakka-Bennett ◽  
Joan Weston ◽  
...  

2014 ◽  
Vol 155 (37) ◽  
pp. 1480-1484
Author(s):  
Réka Faludi

Chronic obstructive pulmonary disease is often associated with cardiovascular diseases, such as pulmonary hypertension, ischemic heart disease, arrhythmias or heart failure. These co-morbidities may cause diagnostic or therapeutic difficulties and significantly worsen the morbidity and mortality of patients with chronic obstructive pulmonary disease. In this work the author reviews special considerations for the treatment of patients with chronic obstructive pulmonary disease who have cardiovascular co-morbidities. Orv. Hetil., 2014, 155(37), 1480–1484.


2009 ◽  
Vol 11 (12) ◽  
pp. 1182-1188 ◽  
Author(s):  
Laura C.M. Boudestein ◽  
Frans H. Rutten ◽  
Maarten J. Cramer ◽  
Jan Willem J. Lammers ◽  
Arno W. Hoes

2021 ◽  
pp. 142-148
Author(s):  
N. V. Bagisheva ◽  
A. V. Mordyk ◽  
I. A. Viktorova ◽  
D. I. Trukhan

Introduction. Chronic obstructive pulmonary disease and cardiovascular diseases (arterial hypertension, ischemic heart disease, chronic heart failure) are among the comorbid conditions that mutually aggravate each other. The addition of tuberculosis in this category of patients requires additional efforts from the doctor to improve treatment outcomes.Purpose. Тo assess the prevalence of chronic obstructive pulmonary disease, arterial hypertension, coronary heart disease and chronic heart failure in patients with newly diagnosed tuberculosis hospitalized in an anti-tuberculosis hospital.Materials and methods. We examined 462 patients with newly diagnosed tuberculosis, hospitalized in a tuberculosis dispensary, aged 17 to 88 years, the median (Me (P25; 75) age was 43.68 (32.00; 54.00) years, including 266 men (57.6%) and 196 women (42.4%) All patients underwent clinical, laboratory, instrumental examination to establish or confirm the diagnosis.Results. The incidence of chronic obstructive pulmonary disease among patients with newly diagnosed tuberculosis was 31.4%, with arterial hypertension – 12.1%, coronary heart disease – 6.1%, chronic heart failure – 6.1%. The incidence of cardiovascular pathology in the group of tuberculosis + chronic obstructive pulmonary disease was 40%, in the group of tuberculosis without chronic obstructive pulmonary disease 6%.Conclusions. The prevalence of comorbid cardiovascular pathology in patients with tuberculosis + chronic obstructive pulmonary disease is significantly higher than among patients with only tuberculosis, which requires the involvement of doctors of various specialties to manage this category of patients to prevent adverse treatment outcomes, disability and mortality.


Sign in / Sign up

Export Citation Format

Share Document